The routine use of the Angio-Seal STS device provides clinical and cost benefits compared with conventional femoral haemostasis methods

Author：

Publisher： Adis International

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.515, 2006-01, pp. : 11-11

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Angio-Seal^™ Arterial Closure Device for Early Ambulation after Elective Percutaneous Coronary Intervention in Patients Receiving Low-dose Enoxaparin

By Lai Y-C Kao H-L Lin Y-H Lin M-S Ho Y-L Chao C-L

The Journal of International Medical Research, Vol. 36, Iss. 5, 2008-09 ,pp. : 1077-1084

Field House Publishing

Access to resources Recommend Favorite

Early initiation of irbesartan provides maximum cost benefits

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 460, 2004-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Use of Routine Healthcare Data in Safe and Cost-Effective Drug Use

By Currie C.J.

Drug Safety, Vol. 22, Iss. 2, 2000-02 ,pp. : 97-102

Adis International

Access to resources Recommend Favorite

Natalizumab shows clinical, cost and QOL benefits

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 514, 2006-01 ,pp. : 1-1

Adis International

Access to resources Recommend Favorite

The Cost-Effectiveness of Group Cognitive Behavioral Therapy Compared with Routine Primary Care for Women with Postnatal Depression in the UK

By Stevenson Matt D. Scope Alison Sutcliffe Paul A.

Value in Health, Vol. 13, Iss. 5, 2010-08 ,pp. : 580-584

Blackwell Publishing

Access to resources Recommend Favorite